erika hamilton, md, on how cdk4/6 inhibitors transformed the management of metastatic breast cancer
Published 3 years ago • 21 plays • Length 1:12
Download video MP4
Download video MP3
Similar videos
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
2:21
erika hamilton, md, regarding the use of cdk 4/6 inhibitors in clinical practice
-
1:43
dr hamilton on implications of destiny-breast06 on the her2-low breast cancer paradigm
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
1:40
erika hamilton, md, on promising treatment options in the management of her2 advanced breast cancer
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
24:55
3個乳癌cdk4/6抑制劑的治療 哪個是最好的?
-
19:46
metastatic breast cancer: what you need to know
-
0:45
nancy lin, md, explores the role of cdk4/6 inhibitors in metastatic breast cancer management
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
1:38
erika hamilton, md | when to use cdk 4/6 inhibitors
-
8:55
cdk4/6 inhibitors in hr metastatic breast cancer
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
6:30
dr. erika hamilton on late stage breast cancer on lx news - nbclx
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
14:51
expert perspectives: targeting advanced er metastatic breast cancer with cdk 4/6 inhibitors
-
1:13
erika hamilton, md, considers the significance of the monarche study & the use of abemaciclib
-
2:27
understanding abemaciclib: a new cdk4/6 inhibitor
-
6:11
hr metastatic breast cancer: upfront cdk4/6 inhibition
-
4:45
cdk4/6 inhibitors for hr metastatic breast cancer
Clip.africa.com - Privacy-policy